I agree it is all beginning to look good in theory.....I say in theory as I believe we are yet to see the market penetration that is going to give Admedus greater than 50% market share in all of their key markets by 2020.
Q1: 1.6M ADAPT sales
Q2: 1.9M ADAPT sales
Q3: 1.5M ADAPT sales
Q4: ??
I suspect something like $2-3M in ADAPT sales Q4. This would be acceptable but Q1 F18 would want to grow to $4-5M and so on...
Long story short the growth curve needs to steepen considerably from here on in. I suspect it has a good chance with the increased/up skilled sales team, a larger product range and new markets coming online.
It looks like they will over deliver slightly on F17 forecast. Hopefully this gives the market some confidence when AHZ present their F18 numbers. Would be good if the forecast is around 40+M in revenue with a $2M-5M profit.
Looking forward, page-2
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.22 |
Change
0.740(6.45%) |
Mkt cap ! $258.3M | |||
| Open | High | Low | Value | Volume |
| $11.50 | $12.25 | $11.49 | $395.2K | 33.29K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $11.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.22 | 127 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |